Tompkins Financial Corp Merck & Co., Inc. Transaction History

Tompkins Financial Corp

$1.04 Billion
Q3 2024

A detailed history of Tompkins Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tompkins Financial Corp holds 98,567 shares of MRK stock, worth $9.66 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

98,567

Previous 97,621 0.97%

Holding current value

$9.66 Million

Previous $12.1 Million 7.38%

% of portfolio

1.08%

Previous 1.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$111.15 - $128.97 $105,147 - $122,005	946 Added 0.97%	98,567 $11.2 Million
Q2 2024 Jul 17, 2024	SELL	$123.8 - $132.96 $209,098 - $224,569	-1,689 Reduced 1.7%	97,621 $12.1 Million
Q1 2024 Apr 08, 2024	BUY	$113.24 - $131.95 $19,590 - $22,827	173 Added 0.17%	99,310 $13.1 Million
Q4 2023 Jan 08, 2024	BUY	$100.18 - $109.02 $883,487 - $961,447	8,819 Added 9.76%	99,137 $10.8 Million
Q3 2023 Nov 20, 2023	BUY	$102.95 - $114.33 $935,094 - $1.04 Million	9,083 Added 11.18%	90,318 $9.3 Million
Q2 2023 Jul 12, 2023	SELL	$108.61 - $118.38 $397,947 - $433,744	-3,664 Reduced 4.32%	81,235 $9.37 Million
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $91,719 - $102,340	-891 Reduced 1.04%	84,899 $9.03 Million
Q4 2022 Jan 06, 2023	SELL	$87.44 - $112.11 $200,150 - $256,619	-2,289 Reduced 2.6%	85,790 $9.52 Million
Q3 2022 Oct 13, 2022	BUY	$84.53 - $94.96 $4,480 - $5,032	53 Added 0.06%	88,079 $7.59 Million
Q2 2022 Jul 14, 2022	SELL	$83.49 - $94.64 $52,932 - $60,001	-634 Reduced 0.72%	88,026 $8.03 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $533,829 - $598,388	7,262 Added 8.92%	88,660 $7.28 Million
Q4 2021 Jan 24, 2022	BUY	$72.28 - $90.54 $42,645 - $53,418	590 Added 0.73%	81,398 $6.24 Million
Q3 2021 Oct 22, 2021	BUY	$71.68 - $78.83 $95,191 - $104,686	1,328 Added 1.67%	80,808 $6.07 Million
Q1 2021 Jun 09, 2021	BUY	$68.86 - $81.11 $147,153 - $173,332	2,137 Added 2.76%	79,480 $6.13 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $5.15 Million - $5.71 Million	-71,696 Reduced 48.11%	77,343 $6.33 Million
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $5.5 Million - $6.1 Million	76,644 Added 105.87%	149,039 $11.5 Million
Q3 2020 Oct 23, 2020	BUY	$73.18 - $82.95 $72,228 - $81,871	987 Added 1.38%	72,395 $6.01 Million
Q2 2020 Jul 29, 2020	BUY	$70.42 - $80.13 $320,270 - $364,431	4,548 Added 6.8%	71,408 $5.52 Million
Q1 2020 Apr 22, 2020	BUY	$63.36 - $87.82 $332,323 - $460,615	5,245 Added 8.51%	66,860 $5.14 Million
Q4 2019 Jan 22, 2020	BUY	$77.58 - $87.54 $350,118 - $395,068	4,513 Added 7.9%	61,615 $5.6 Million
Q3 2019 Oct 17, 2019	SELL	$76.08 - $82.93 $12,781 - $13,932	-168 Reduced 0.29%	57,102 $4.81 Million
Q2 2019 Jul 17, 2019	BUY	$69.84 - $81.59 $155,743 - $181,945	2,230 Added 4.05%	57,270 $4.8 Million
Q1 2019 Apr 30, 2019	BUY	$69.58 - $79.36 $1,461 - $1,666	21 Added 0.04%	55,040 $4.58 Million
Q1 2019 Apr 17, 2019	BUY	$69.58 - $79.36 $44,113 - $50,314	634 Added 1.17%	55,019 $3.9 Million
Q4 2018 Jan 22, 2019	SELL	$65.24 - $75.71 $41,362 - $48,000	-634 Reduced 1.15%	54,385 $4.15 Million
Q3 2018 Oct 18, 2018	SELL	$57.69 - $67.84 $77,881 - $91,584	-1,350 Reduced 2.39%	55,019 $3.9 Million
Q2 2018 Jul 18, 2018	BUY	$50.83 - $59.72 $83,005 - $97,522	1,633 Added 2.98%	56,369 $3.42 Million
Q1 2018 Apr 26, 2018	BUY	$50.96 - $59.23 $39,443 - $45,844	774 Added 1.43%	54,736 $2.98 Million
Q4 2017 Jan 24, 2018	BUY	$51.62 - $61.64 $64,008 - $76,433	1,240 Added 2.35%	53,962 $3.04 Million
Q3 2017 Oct 17, 2017	BUY	$58.67 - $63.13 $3.09 Million - $3.33 Million	52,722	52,722 $3.38 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Merck & Co., Inc. Transaction History